On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer.
Zanotti-Fregonara
Paolo
P
Hindié
Elif
E
D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D011836:Radiation Tolerance / Q000187:drug effects; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000556:secondary* / Q000628:therapy*; D013972:Thyrotropin / Q000627:therapeutic use*; D016896:Treatment Outcome
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; D013972:Thyrotropin
Thyroid. 2010 Mar;20(3):257-63
20187781
Eur J Nucl Med Mol Imaging. 2003 Jul;30(7):974-81
12734689
Eur J Endocrinol. 2006 Jun;154(6):787-803
16728537
J Cell Sci. 2009 Sep 15;122(Pt 18):3393-402
19706688
J Clin Endocrinol Metab. 2004 Feb;89(2):585-90
14764766
Clin Nucl Med. 2009 May;34(5):316-7
19387216
J Clin Endocrinol Metab. 1999 Sep;84(9):3228-34
10487692
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1251-4
20306039
Thyroid. 2009 Nov;19(11):1167-214
19860577
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
16684830
Clin Endocrinol (Oxf). 2006 Oct;65(4):519-23
16984246
Endocr Relat Cancer. 2005 Mar;12(1):49-64
15788638
Endocr Relat Cancer. 2007 Sep;14(3):799-807
17914109
Thyroid. 2004 Jun;14(6):465-7
15242576
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2267-76
20661558